|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3288980 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16724512.5 |
| Europos patento paraiškos padavimo data | 2016-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/029878 |
| Data | 2016-04-28 |
| (87) | Numeris | WO 2016/176504 |
| Data | 2016-11-03 |
| (30) | Numeris | Data | Šalis |
| 201562153954 P | 2015-04-28 | US |
| (72) |
YANG, Arvin, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |
| TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |